|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2000-1-4
|
|
pubmed:abstractText |
To determine whether pretreatment clinical features and molecular markers, together with changes in these factors, can predict treatment response and survival in patients with primary operable breast cancer who receive neoadjuvant therapy.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/DNA, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/Methotrexate,
http://linkedlifedata.com/resource/pubmed/chemical/Mitoxantrone,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Estrogen,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Progesterone,
http://linkedlifedata.com/resource/pubmed/chemical/Tamoxifen,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
17
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3058-63
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:10506600-Adult,
pubmed-meshheading:10506600-Aged,
pubmed-meshheading:10506600-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:10506600-Breast Neoplasms,
pubmed-meshheading:10506600-DNA, Neoplasm,
pubmed-meshheading:10506600-Female,
pubmed-meshheading:10506600-Genes, Tumor Suppressor,
pubmed-meshheading:10506600-Humans,
pubmed-meshheading:10506600-Lymphatic Metastasis,
pubmed-meshheading:10506600-Methotrexate,
pubmed-meshheading:10506600-Middle Aged,
pubmed-meshheading:10506600-Mitoxantrone,
pubmed-meshheading:10506600-Neoadjuvant Therapy,
pubmed-meshheading:10506600-Ploidies,
pubmed-meshheading:10506600-Predictive Value of Tests,
pubmed-meshheading:10506600-Prognosis,
pubmed-meshheading:10506600-Receptors, Estrogen,
pubmed-meshheading:10506600-Receptors, Progesterone,
pubmed-meshheading:10506600-Tamoxifen,
pubmed-meshheading:10506600-Treatment Outcome,
pubmed-meshheading:10506600-Tumor Markers, Biological
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Biologic markers as predictors of clinical outcome from systemic therapy for primary operable breast cancer.
|
|
pubmed:affiliation |
Departments of Medicine and Computing, The Royal Marsden Hospital, Sutton, Surrey, United Kingdom. mdcccn@nus.edu.sg
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
